- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Therapy-Related Acute Myeloid Leukemia
Total 6560 results
-
Beijing Boren HospitalRecruitingAcute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Relapse LeukemiaChina
-
Goethe UniversityStichting Hemato-Oncologie voor Volwassenen Nederland; Polish Adult Leukemia... and other collaboratorsTerminatedMyelodysplastic Syndromes (MDS) | Acute Myeloid Leukaemia (AML)Germany, Netherlands
-
Astellas Pharma Global Development, Inc.RecruitingAcute Myeloid Leukemia (AML) | FLT3-mutated Acute Myeloid LeukemiaUnited States
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedRecurrent Adult Acute Myeloid Leukemia | Refractory Acute Myeloid LeukemiaUnited States
-
Verastem, Inc.WithdrawnRelapsed or Refractory Acute Myeloid Leukemia | Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia
-
Osaka UniversityJapan Agency for Medical Research and DevelopmentRecruitingAcute Myeloid Leukemia in RemissionJapan
-
Ge ZhengRecruitingAcute Myeloid Leukemia in RemissionChina
-
UNC Lineberger Comprehensive Cancer CenterMerck Sharp & Dohme LLCActive, not recruitingAcute Myeloid Leukemia, in RelapseUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedUntreated Adult Acute Myeloid LeukemiaUnited States
-
Novartis PharmaceuticalsNo longer availableFLT3-mutated Acute Myeloid LeukemiaCanada
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)WithdrawnUntreated Adult Acute Myeloid LeukemiaUnited States
-
Case Comprehensive Cancer CenterActive, not recruitingMyelodysplastic Syndromes | Refractory Acute Myeloid Leukemia | Relapsed Acute Myelomonocytic LeukemiaUnited States
-
Masonic Cancer Center, University of MinnesotaCompletedRelapsed Acute Myelogenous Leukemia | Refractory Acute Myelogenous LeukemiaUnited States
-
Kartos Therapeutics, Inc.TerminatedRelapsed or Refractory Acute Myeloid Leukemia (AML) | Acute Myeloid Leukemia (AML), Secondary to Myeloproliferative Neoplasms (MPN)United States, Spain, Korea, Republic of, Belgium, United Kingdom, Hungary, France, Germany, Israel, Australia, Italy, Poland
-
Nantes University HospitalRecruitingAcute Myeloid Leukemia in RemissionFrance
-
AbbVieActive, not recruitingCancer | Acute Myeloid Leukemia (AML)United States, Australia, Brazil, Canada, China, Czechia, France, Germany, Greece, Hungary, Israel, Italy, Japan, Korea, Republic of, Spain, Switzerland, Taiwan, United Kingdom
-
Daiichi Sankyo, Inc.CompletedAMLUnited States, Korea, Republic of, Taiwan, United Kingdom, France, Australia, Spain, Italy, Canada, Singapore, Germany, Netherlands, Hong Kong, Belgium, Croatia, Czechia, Hungary, Poland, Serbia
-
University of FreiburgCompletedAcute Myeloid Leukemia, in RelapseGermany
-
National Cancer Institute (NCI)CompletedAcute Myeloid Leukemia | Untreated Adult Acute Myeloid LeukemiaUnited States, Canada
-
Gemin XCompleted
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Astellas Pharma IncCompletedAcute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Chronic Myelomonocytic Leukemia | Previously Treated Myelodysplastic Syndrome | Recurrent Adult Acute Myeloid Leukemia | Myelodysplastic Syndrome | Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11 | Adult Acute... and other conditionsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedAcute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Myelodysplastic Syndrome | Recurrent Acute Myeloid Leukemia | Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Therapy-Related Acute Myeloid Leukemia and other conditionsUnited States
-
Vastra Gotaland RegionRecruitingPediatric Acute Myeloblastic LeukemiaBelgium, Denmark, Estonia, Finland, Hong Kong, Iceland, Netherlands, Norway, Sweden
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Nanfang Hospital of Southern Medical UniversityPeking University People's Hospital; Guangzhou First People's Hospital; Sun Yat-Sen... and other collaboratorsRecruitingCore Binding Factor Acute Myeloid LeukemiaChina
-
Kronos BioTerminatedNucleophosmin 1-mutated Acute Myeloid LeukemiaIsrael, Spain, France, United States, Czechia, Hungary, Korea, Republic of, Germany, Italy, Poland, Brazil, Canada
-
National Cancer Institute (NCI)CompletedAcute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Chronic Myelomonocytic Leukemia | Previously Treated Myelodysplastic Syndrome | Recurrent Adult Acute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Untreated Adult Acute Myeloid Leukemia | Adult Acute Myeloid Leukemia... and other conditionsUnited States
-
National Cancer Institute (NCI)Active, not recruitingPreviously Treated Myelodysplastic Syndrome | Secondary Acute Myeloid Leukemia | Recurrent Acute Myeloid Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | Refractory Myelodysplastic Syndrome | Secondary Myelodysplastic Syndrome | Recurrent Acute Myeloid Leukemia,...United States
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedChildhood Acute Monoblastic Leukemia (M5a) | Childhood Acute Monocytic Leukemia (M5b) | Childhood Acute Myeloblastic Leukemia Without Maturation (M1) | Childhood Acute Myelomonocytic Leukemia (M4) | Childhood Acute Myeloid Leukemia/Other Myeloid MalignanciesUnited States
-
Astellas Pharma Global Development, Inc.Active, not recruitingLeukemia, Acute Myeloid (AML)Japan, United States, Belgium, Canada, France, Germany, Israel, Italy, Korea, Republic of, Poland, Spain, Taiwan, Turkey, United Kingdom
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedRecurrent Adult Acute Myeloid Leukemia | Untreated Adult Acute Myeloid LeukemiaUnited States
-
National Cancer Institute (NCI)TerminatedRecurrent Adult Acute Myeloid Leukemia | Untreated Adult Acute Myeloid LeukemiaUnited States
-
Igenica Biotherapeutics, Inc.CompletedAcute Myeloid Leukemia | Acute Myelogenous LeukemiaUnited States
-
Acute Leukemia French AssociationAssistance Publique - Hôpitaux de ParisWithdrawnAcute Myeloid LeukemiaFrance
-
Technische Universität DresdenCompletedLeukemia, Nonlymphoblastic, AcuteGermany
-
Hoffmann-La RocheCompletedNeoplasms, Myelogenous Leukemia, AcuteUnited States, Canada
-
University of Southern CaliforniaNational Cancer Institute (NCI)TerminatedAcute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Chronic Myelomonocytic Leukemia | Previously Treated Myelodysplastic Syndrome | Recurrent Acute Myeloid Leukemia With Myelodysplasia-Related Changes | Recurrent Adult Acute Myeloid LeukemiaUnited States
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingAcute Myeloid LeukemiaFrance
-
First Affiliated Hospital Xi'an Jiaotong UniversityRecruitingLeukemia, Myelomonocytic, AcuteChina
-
Indiana UniversityOSI PharmaceuticalsCompletedLeukemia, Myelomonocytic, AcuteUnited States
-
University of FloridaTerminatedAcute Myeloid Leukemia | Leukemia | Acute Myelogenous LeukemiaUnited States
-
Seagen Inc.CompletedAcute Myeloid Leukemia | Acute Myelogenous LeukemiaUnited States
-
Technische Universität DresdenCompletedLeukemia, Nonlymphocytic, AcuteGermany
-
Massachusetts General HospitalCompleted
-
Zhejiang ACEA Pharmaceutical Co. Ltd.Recruiting
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaUnknownAdult Acute Myeloid Leukemia in RemissionItaly
-
Daiichi Sankyo, Inc.No longer availableAcute Myeloid Leukemia With Gene Mutations
-
National Cancer Institute (NCI)CompletedAcute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Recurrent Adult Acute Myeloid Leukemia | Adult Acute Myeloid Leukemia in Remission | Myelodysplastic Syndrome With Excess Blasts | Adult Acute Monocytic Leukemia | Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11 and other conditionsUnited States, Israel, Peru
-
Arog Pharmaceuticals, Inc.CompletedAcute Myeloid Leukemia With FLT3 Activating Mutations That Has Relapsed or Been Refractory After One or More Prior TherapiesUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteJazz PharmaceuticalsRecruitingAcute Myeloid Leukemia With FLT3/ITD MutationUnited States